During the past decade, BCG Oncology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BCG Oncology" #1 sponsor was "CG Oncology, Inc." with 4 trials, followed by "Bioniche Life Sciences Inc." with 2 trials sponsored, "Endo Pharmaceuticals" with 2 trials sponsored, "Halozyme Therapeutics" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BCG Oncology" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Hoosier Cancer Research Network" with 1 trials as a collaborator and "US Biotest, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "BCG Oncology" are "Bladder Cancer" (9 trials), "Carcinoma in Situ" (4 trials), "Bladder Neoplasms" (2 trials), "Superficial Bladder Cancer" (2 trials) and "Transitional Cell Carcinoma" (2 trials). Many other conditions were trialed in "BCG Oncology" in a lesser frequency.

Most popular intervention types in "BCG Oncology" are "Biological" (11 trials), "Drug" (11 trials), "Other" (5 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "CG0070" (2 trials), "Cetrelimab" (2 trials), "Chemophase" (2 trials), "Gemcitabine" (2 trials) and "Mitomycin C" (2 trials). Other intervention names were less common.

The vast majority of trials in "BCG Oncology" are 20 trials for "All" genders.

Currently, there are NaN active trials in "BCG Oncology". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in BCG Oncology, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in BCG Oncology, 5 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".